Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.59B |
| 2 |
TotalEnergies
TTE
|
+$1.27B |
| 3 |
Warner Bros
WBD
|
+$838M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$782M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$707M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$2.77B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.27B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.6B |
| 5 |
Microsoft
MSFT
|
+$1.58B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.21% |
| 2 | Financials | 9.57% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Healthcare | 7.31% |
| 5 | Communication Services | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
ANI Pharmaceuticals
ANIP
$1.88B
| $31.6M | ﹤0.01% |
400,278
+21,252
| +6% | +$1.84M |
|
1927
Amylyx Pharmaceuticals
AMLX
$2.69B
| $31.6M | ﹤0.01% |
2,613,221
+602,588
| +30% | +$8.18M |
|
1928
Herbalife
HLF
$1.19B
| $31.6M | ﹤0.01% |
2,448,586
+352,724
| +17% | +$3.74M |
|
1929
Tenaris
TS
$27B
| $31.5M | ﹤0.01% |
819,576
+114,393
| +16% | +$4.41M |
|
1930
PUT
Linde
LIN
$226B
| $31.5M | ﹤0.01% |
73,800
+47,100
| +176% | +$20.2M |
|
1931
HNI Corp
HNI
$3.53B
| $31.5M | ﹤0.01% |
748,502
+15,163
| +2% | +$640K |
|
1932
PUT
Agnico Eagle Mines
AEM
$85B
| $31.5M | ﹤0.01% |
185,600
| – | – |
|
1933
National Vision
EYE
$1.8B
| $31.4M | ﹤0.01% |
1,217,441
+352,040
| +41% | +$9.47M |
|
1934
Radian Group
RDN
$4.82B
| $31.4M | ﹤0.01% |
871,412
+110,981
| +15% | +$3.87M |
|
1935
First Financial Bankshares
FFIN
$4.97B
| $31.4M | ﹤0.01% |
1,049,679
+295,267
| +39% | +$9.3M |
|
1936
MarketAxess Holdings
MKTX
$5.72B
| $31.3M | ﹤0.01% |
172,598
+38,947
| +29% | +$6.65M |
|
1937
Generac Holdings
GNRC
$12.5B
| $31.2M | ﹤0.01% |
229,026
-9,515
| -4% | -$1.54M |
|
1938
Sibanye-Stillwater
SBSW
$7B
| $31.2M | ﹤0.01% |
2,190,327
-2,170,521
| -50% | -$26.3M |
|
1939
Adient
ADNT
$1.48B
| $31.2M | ﹤0.01% |
1,627,404
-624,750
| -28% | -$13.1M |
|
1940
Xenon Pharmaceuticals
XENE
$6.24B
| $31.2M | ﹤0.01% |
696,047
-24,612
| -3% | -$1.03M |
|
1941
AXIS Capital
AXS
$7.62B
| $31.2M | ﹤0.01% |
291,015
+108,016
| +59% | +$10.7M |
|
1942
AutoNation
AN
$6.99B
| $31.2M | ﹤0.01% |
150,918
-61,289
| -29% | -$12.7M |
|
1943
United Parks & Resorts
PRKS
$2.09B
| $31M | ﹤0.01% |
854,226
+255,063
| +43% | +$10.6M |
|
1944
Tarsus Pharmaceuticals
TARS
$2.85B
| $31M | ﹤0.01% |
378,704
+37,692
| +11% | +$2.81M |
|
1945
CALL
US Global Jets ETF
JETS
$803M
| $30.9M | ﹤0.01% |
+1,100,000
| New | +$28.6M |
|
|
1946
PUT
US Global Jets ETF
JETS
$803M
| $30.9M | ﹤0.01% |
+1,100,000
| New | +$28.6M |
|
1947
PUT
Pfizer
PFE
$149B
| $30.9M | ﹤0.01% |
1,240,000
+300,000
| +32% | +$7.57M |
|
1948
Halozyme
HALO
$10.2B
| $30.8M | ﹤0.01% |
458,139
-226,384
| -33% | -$15.2M |
|
1949
OGE Energy
OGE
$9.67B
| $30.8M | ﹤0.01% |
721,469
+22,182
| +3% | +$989K |
|
1950
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.87B
| $30.8M | ﹤0.01% |
+1,050,000
| New | +$31.7M |
|
Similar funds
Goldman Sachs's Q4 2025 Portfolio in Review
As of Q4 2025, Goldman Sachs held 6,954 positions worth $815B, down 0.25% from $817B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q4 2025 filing shows 640 new, 3,023 increased, 2,153 reduced and 543 closed positions. Its largest new stake was SunocoCorp LLC: 2,575,806 shares worth $127M. The largest sale was TC Energy, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q4 2025 buy was SunocoCorp LLC: 2,575,806 shares worth $127M.
- Goldman Sachs added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2025, an estimated $1.59B increase.
- Goldman Sachs's biggest Q4 2025 reduction was TC Energy, cutting an estimated $2.77B.
- Goldman Sachs fully exited Verona Pharma in Q4 2025, selling an estimated $207M.
- Goldman Sachs's ten largest holdings make up 22% of its $815B portfolio in Q4 2025.
- Goldman Sachs opened 640 new positions and closed 543 in Q4 2025.
- Goldman Sachs's portfolio value fell 0.25% quarter-over-quarter to $815B.
Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.